PIK3CA-RELATED VASCULAR MALFORMATIONS (PRVM)

Clinical trials for PIK3CA-RELATED VASCULAR MALFORMATIONS (PRVM) explained in plain language.

Never miss a new study

Get alerted when new PIK3CA-RELATED VASCULAR MALFORMATIONS (PRVM) trials appear

Sign up with your email to follow new studies for PIK3CA-RELATED VASCULAR MALFORMATIONS (PRVM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets root cause of rare, painful growth disorders

Disease control Recruiting now

This early-stage study is testing an experimental drug called CYH33 for people with rare disorders that cause abnormal tissue and blood vessel overgrowth (PROS and PRVM). The main goals are to find a safe dose and see if the drug can shrink the overgrown lesions by at least 20% a…

Matched conditions: PIK3CA-RELATED VASCULAR MALFORMATIONS (PRVM)

Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

PIK3CA-RELATED VASCULAR MALFORMATIONS (PRVM)

Get alerted when new PIK3CA-RELATED VASCULAR MALFORMATIONS (PRVM) trials appear

New drug trial targets root cause of rare, painful growth disorders